EUVIMEDEUVIMED entdecken
Crossref

Quo Vadis Analytical Procedure Development and Validation?

C. Burgess, R.D. McDowall

Spectroscopy · 01.09.2022 · 8-14

DOI: 10.56530/spectroscopy.mf9790d5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Spectroscopy, online erschienen am 01.09.2022. Verfasst von C. Burgess und 1 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

What do the draft publications ICH Q2(R2) and Q14 for analytical procedure validation and development mean for a regulated Good Manufacturing Practice (GMP) laboratory? Are they consistent with the approach taken by United States Pharmacopoeia (USP) on Analytical Procedure Lifecycle? Why does it take two documents to describe what USP can do in one?

Zitieren

APA

Burgess, C., & McDowall, R. (2022). Quo Vadis Analytical Procedure Development and Validation?. Spectroscopy, 8-14. https://doi.org/10.56530/spectroscopy.mf9790d5

Vancouver

Burgess C, McDowall R. Quo Vadis Analytical Procedure Development and Validation?. Spectroscopy. 2022:8-14. doi:10.56530/spectroscopy.mf9790d5

BibTeX
@article{Burgess2022,
  author = {Burgess, C. and McDowall, R.D.},
  title = {Quo Vadis Analytical Procedure Development and Validation?},
  journal = {Spectroscopy},
  year = {2022},
  pages = {8--14},
  doi = {10.56530/spectroscopy.mf9790d5}
}
Kostenlos starten →